[Therapeutic strategy in venous thromboembolic disease (VTD)].
D000465:Algorithms; D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use; D001780:Blood Coagulation Tests; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006493:Heparin / Q000009:adverse effects / Q000627:therapeutic use; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use; D006801:Humans; D008297:Male; D011247:Pregnancy; D011655:Pulmonary Embolism / Q000097:blood / Q000188:drug therapy*; D013923:Thromboembolism / Q000097:blood / Q000188:drug therapy*; D013924:Thrombophlebitis / Q000097:blood / Q000188:drug therapy*
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight; D006493:Heparin
Estrategia terapéutica en la enfermedad tromboembólica venosa (ETV).